home / stock / aezs / aezs news

AEZS News and Press, Aeterna Zentaris Inc.

Stock Information
Company Name: Aeterna Zentaris Inc.
Stock Symbol: AEZS
Market: NASDAQ
Website: zentaris.com
Menu
AEZS AEZS Quote AEZS Short AEZS News AEZS Articles AEZS Message Board
Get AEZS Alerts

News, Short Squeeze, Breakout and More Instantly...
AEZS - How the (AEZS) price action is used to our Advantage

2024-07-17 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
AEZS - Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders

TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for he...

AEZS - Aeterna Zentaris Inc. (NASDAQ: AEZS) Leading the Way in Tuesday Trading Based on Percentage Gain

Aeterna Zentaris Inc. (NASDAQ: AEZS) is one of today's top gainers. The company's shares have moved 24.97% on the day to $6.7. Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimore...

AEZS - US Companies Moving the Markets, Evening edition
Thu, Jun 20, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 3.5% to $130.78 on volume of 504,910,586 shares Nikola Corporation (NKLA) fell 31.5% to $0.3296 on volume of 265,124,783 shares SMX (Security Matters) Public Limited Company (SMX) rose 35.1% to $0.1608 o...
AEZS - How To Trade (AEZS)

2024-06-17 06:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

AEZS - Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

Company expects to report top-line data and complete study results in Q3 2024 TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing a...

AEZS - Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (“Ceapro”), two innovative biopharmaceutical development companies, ...
AEZS - Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date

TORONTO, ONTARIO, May 29, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, t...

AEZS - Aeterna Zentaris Announces Details Regarding Transaction with Ceapro

TORONTO, ON, May 17, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ” or the “ Company ”) announces that it has finalized certain details regarding the previously announced merger of equals transaction (the “ Tra...

AEZS - AEZS Stock Earnings: AEterna Zentaris Misses EPS, Misses Revenue for Q1 2024

2024-05-15 07:53:03 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips AEterna Zentaris (NASDAQ: AEZS ) just reported results for the first quarter of 2024. AEterna Zentaris reported earnings per share of -$4.74. This was below the analyst es...
Next 10